Marken recognizes the pharma industry’s increased focus on rare disease treatments and the complexity of safely transporting them to patients residing in multiple countries, each with its own unique customs and regulatory requirements. Marken’s Direct to Patient service utilizes its team of experts in customs and trade compliance along with its extensive network of depot facilities and strategically located distribution centers throughout the world to provide timely global packaging, transport and tracking of orphan drug materials within regulatory, temperature and time constraints.
- Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor
- Marken Delivers Compassionate Use Dose of Emergency Medication to Critical Pediatric Patient
- Dissolving boundaries in worldwide clinical trial logistics
- The World is Changing, Talk to Marken